DrugRisk Alerts Byetta Users of Cancer Litigation

July 16, 2013

DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

New York, NY (PRWEB) July 16, 2013

The diabetes drug resource center at DrugRisk.com is announcing updated information for patients taking the medication Byetta. A federal panel will decide the fate of a growing number of lawsuits alleging pancreatic cancer next week as health experts release new warnings*.

DrugRisk was created to provide those taking popular prescription drugs with the latest recalls, alerts, research and litigation news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Byetta is an injectable medication designed to help control blood sugar in those with type-II diabetes. Last year the drug sold over $300 million for maker Bristol-Myers Squibb**.

The resource center has added warnings about a possible Byetta relation to cancer. A 2011 study from UCLA suggested the drug could increase the risk of pancreatic cancer and thyroid cancer***. This year, the Journal for the American Medical Association also advised that drugs like Byetta can double the risk of pancreatitis, a major risk factor for pancreatic cancer****.

After the American Diabetes Association called for new, independent testing of medications like Byetta, the British Medical Journal reported the drugs could be more dangerous than believed, but drug makers haven’t handed over data to allow new testing*.

Due to the number of patients filing a Byetta lawsuit alleging cancer, the Judicial Panel on Multidistrict Litigation will meet on July 25th to determine consolidation of cases to a special federal court. (In Re: Incretins Products Liability, Sales and Marketing Litigation, MDL 2452, United States Judicial Panel on Multidistrict Litigation).

Anyone affected by cancer after taking Byetta is encouraged to visit the DrugRisk center or speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Byetta lawsuits.

For more information on the research, side effects and litigation news related to Byetta and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*MedPage Today, 6/12/13; medpagetoday.com/Endocrinology/Diabetes/39803

**Bloomberg, 2/25/13; bloomberg.com/news/2013-02-25/merck-bristol-diabetes-drugs-linked-to-pancreatitis-risk.html

***Gastroenterology, July 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf

****JAMA Internal Medicine, 2/25/13; archinte.jamanetwork.com/article.aspx?articleid=1656537

For the original version on PRWeb visit: http://www.prweb.com/releases/byetta-side-effects/pancreatic-cancer/prweb10930301.htm

Source: prweb

comments powered by Disqus